A
AIM ImmunoTech Inc
F:HXB2
AIM ImmunoTech Inc
F:HXB2
Price:
0.061
EUR
-41.9%
Market Closed
Market Cap:
€3.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
AIM ImmunoTech Inc
F:HXB2
|
US |
|
W
|
Wacker Chemie AG
SWB:WCH
|
DE |
|
G
|
GTI Resources Ltd
XBER:3G4
|
AU |
|
Nintendo Co Ltd
F:NTOA
|
JP |
|
Y
|
Yangarra Resources Ltd
F:702B
|
CA |
|
Varonis Systems Inc
LSE:0VOU
|
US |
|
Andritz AG
OTC:ADRZY
|
AT |
|
CASH Financial Services Group Ltd
F:CFN
|
HK |
|
Bonduelle SA
PAR:BON
|
FR |
|
Anmol India Ltd
BSE:542437
|
IN |
|
CoStar Group Inc
F:RLG
|
US |
|
Annaly Capital Management Inc
F:AAYA
|
US |
|
A
|
Asset World Corp PCL
SET:AWC
|
TH |
|
M
|
Marqeta Inc
NASDAQ:MQ
|
US |
|
S
|
SoftBank Corp
XBER:3AG1
|
JP |
|
Amcor PLC
NYSE:AMCR
|
UK |
|
S
|
Sayona Mining Ltd
OTC:SYAXF
|
AU |
|
M
|
Max Estates Ltd
NSE:MAXESTATES
|
IN |
|
Hexagon Composites ASA
LSE:0EOF
|
NO |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of HXB2.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HXB2
Multiples-Based Value
Not Available
